致善生物完成1000万美元战略融资
体外分子诊断试剂及设备研发商致善生物又获新融资了。据了解,该轮融资1000万美元,
Last Update:
June 7, 2021
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.